{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:55:40Z","timestamp":1794383740679,"version":"4.9.0"},"publisher-location":"New York, NY","reference-count":114,"publisher":"Springer New York","isbn-type":[{"value":"9781441958181","type":"print"},{"value":"9781441958198","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-4419-5819-8_10","type":"book-chapter","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T21:08:34Z","timestamp":1293743314000},"page":"117-130","source":"Crossref","is-referenced-by-count":8,"title":["Gene- and Cell-Based Approaches for Neurodegenerative Disease"],"prefix":"10.1007","author":[{"given":"Klaudia Urbaniak","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester","family":"Yarbrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ciacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"5","key":"10_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.stem.2007.09.002","volume":"1","author":"H. Suh","year":"2007","unstructured":"Suh H, Consiglio A, Ray J et al. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell 2007; 1(5):515\u201328.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.42.1.115","volume":"42","author":"D.L. Bachman","year":"1992","unstructured":"Bachman DL, Wolf PA, Linn R et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992; 42(1):115\u20139.","journal-title":"Neurology"},{"issue":"2","key":"10_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2307\/3350099","volume":"68","author":"D.A. Evans","year":"1990","unstructured":"Evans DA. Estimated prevalence of Alzheimer\u2019s disease in the United States. Milbank Q 1990; 68(2):267\u201389.","journal-title":"Milbank Q"},{"issue":"8","key":"10_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","volume":"60","author":"L.E. Hebert","year":"2003","unstructured":"Hebert LE, Scherr PA, Bienias JL et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003; 60(8):1119\u201322.","journal-title":"Arch Neurol"},{"issue":"4","key":"10_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0733-8619(05)70229-2","volume":"18","author":"D.P. Perl","year":"2000","unstructured":"Perl DP. Neuropatholog y of Alzheimer\u2019s disease and related disorders. Neurol Clin 2000; 18(4):847\u201364.","journal-title":"Neurol Clin"},{"issue":"4994","key":"10_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1899488","volume":"251","author":"V.M. Lee","year":"1991","unstructured":"Lee VM, Balin BJ, Otvos L Jr et al. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991; 251(4994):675\u20138.","journal-title":"Science"},{"issue":"3","key":"10_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.410050311","volume":"5","author":"K. Wisniewski","year":"1979","unstructured":"Wisniewski K, Jervis GA, Moretz RC et al. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia. Ann Neurol 1979; 5(3):288\u201394.","journal-title":"Ann Neurol"},{"issue":"5733","key":"10_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K. Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005; 309(5733):476\u201381.","journal-title":"Science"},{"issue":"17","key":"10_CR9","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1056\/NEJMcibr055003","volume":"353","author":"R.E. Tanzi","year":"2005","unstructured":"Tanzi RE. Tangles and neurodegenerative disease\u2014a surprising twist. N Engl J Med 2005; 353(17):1853\u20135.","journal-title":"N Engl J Med"},{"issue":"3","key":"10_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.61.3.378","volume":"61","author":"D.A. Bennett","year":"2004","unstructured":"Bennett DA, Schneider JA, Wilson RS et al. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 2004; 61(3):378\u201384.","journal-title":"Arch Neurol"},{"issue":"6","key":"10_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0197-4580(99)00063-9","volume":"20","author":"E. Grober","year":"1999","unstructured":"Grober E, Dickson D, Sliwinski MJ et al. Memory and mental status correlates of modified Braak staging. Neurobiol Aging 1999; 20(6):573\u20139.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10_CR12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ajgp.12.2.146","volume":"12","author":"A. Lleo","year":"2004","unstructured":"Lleo A, Berezovska O, Growdon JH et al. Clinical, pathological and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am J Geriatr Psychiatry 2004; 12(2):146\u201356.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"G.G. Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120(3):885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5226","key":"10_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E. Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science 1995; 269(5226):973\u20137.","journal-title":"Science"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","volume":"924","author":"D.J. Selkoe","year":"2000","unstructured":"Selkoe DJ. Toward a comprehensive theory for Alzheimer\u2019s disease. Hypothesis: Alzheimer\u2019s disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 2000; 924:17\u201325.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","volume":"114","author":"R.A. Rissman","year":"2004","unstructured":"Rissman RA, Poon WW, Blurton-Jones M et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 2004; 114(1):121\u201330.","journal-title":"J Clin Invest"},{"issue":"1","key":"10_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1750-3639.1993.tb00728.x","volume":"3","author":"E. Masliah","year":"1993","unstructured":"Masliah E, Terry R. The role of synaptic proteins in the pathogenesis of disorders of the central nervous system. Brain Pathol 1993; 3(1):77\u201385.","journal-title":"Brain Pathol"},{"issue":"4","key":"10_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"R.D. Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30(4):572\u201380.","journal-title":"Ann Neurol"},{"issue":"2","key":"10_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.410100209","volume":"10","author":"R.D. Terry","year":"1981","unstructured":"Terry RD, Peck A, DeTeresa R et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10(2):184\u201392.","journal-title":"Ann Neurol"},{"issue":"4","key":"10_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H. Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"L.M. Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol 2006; 5(6):525\u201335.","journal-title":"Lancet Neurol"},{"issue":"15","key":"10_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"A.E. Lang","year":"1998","unstructured":"Lang AE, Lozano AM. Parkinson\u2019s disease. First of two parts. N Engl J Med 1998; 339(15):1044\u201353.","journal-title":"N Engl J Med"},{"issue":"11","key":"10_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"S.K. Eeden Van Den","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL et al. Incidence of Parkinson\u2019s disease: variation by age, gender and race\/ethnicity. Am J Epidemiol 2003; 157(11):1015\u201322.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"D.J. Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56(1):33\u20139.","journal-title":"Arch Neurol"},{"issue":"4","key":"10_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"J.W. Langston","year":"2006","unstructured":"Langston JW. The Parkinson\u2019s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 2006; 59(4):591\u20136.","journal-title":"Ann Neurol"},{"issue":"11","key":"10_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"C.F. Lippa","year":"2007","unstructured":"Lippa CF, Duda JE, Grossman M et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology and biomarkers. Neurology 2007; 68(11):812\u20139.","journal-title":"Neurology"},{"issue":"1","key":"10_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archneur.59.1.102","volume":"59","author":"H. Apaydin","year":"2002","unstructured":"Apaydin H, Ahlskog JE, Parisi JE et al. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol 2002; 59(1):102\u201312.","journal-title":"Arch Neurol"},{"issue":"6","key":"10_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/BF00296485","volume":"88","author":"H. Braak","year":"1994","unstructured":"Braak H, Braak E, Yilmazer D et al. Amygdala pathology in Parkinson\u2019s disease. Acta Neuropathol 1994; 88(6):493\u2013500.","journal-title":"Acta Neuropathol"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0079-6123(08)64021-2","volume":"117","author":"H. Braak","year":"1998","unstructured":"Braak H, de Vos RA, Jansen EN et al. Neuropathological hallmarks of Alzheimer\u2019s and Parkinson\u2019s diseases. Prog Brain Res 1998; 117:267\u201385.","journal-title":"Prog Brain Res"},{"issue":"3","key":"10_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","volume":"52","author":"M.S. Pollanen","year":"1993","unstructured":"Pollanen MS, Dickson DW, Bergeron C. Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 1993; 52(3):183\u201391.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1385\/NMM:1:2:95","volume":"1","author":"N.B. Cole","year":"2002","unstructured":"Cole NB, Murphy DD. The cell biology of alpha-synuclein: a sticky problem? Neuromolecular Med 2002; 1(2):95\u2013109.","journal-title":"Neuromolecular Med"},{"issue":"1","key":"10_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/1531-8257(199901)14:1<6::AID-MDS1004>3.0.CO;2-L","volume":"14","author":"L.I. Golbe","year":"1999","unstructured":"Golbe LI. Alpha-synuclein and Parkinson\u2019s disease. Mov Disord 1999; 14(1):6\u20139.","journal-title":"Mov Disord"},{"issue":"8","key":"10_CR33","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H. Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN et al. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005; 64(8):1404\u201310.","journal-title":"Neurology"},{"issue":"5","key":"10_CR34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K. Tredici Del","year":"2002","unstructured":"Del Tredici K, Rub U, De Vos RA et al. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002; 61(5):413\u201326.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4587","key":"10_CR35","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"J.W. Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219(4587):979\u201380.","journal-title":"Science"},{"issue":"3","key":"10_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","volume":"44","author":"C. Pifl","year":"1991","unstructured":"Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 1991; 44(3):591\u2013605.","journal-title":"Neuroscience"},{"issue":"2","key":"10_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R. Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 1998; 18(2):106\u20138.","journal-title":"Nat Genet"},{"issue":"5321","key":"10_CR38","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"M.H. Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 1997; 276(5321):2045\u20137.","journal-title":"Science"},{"issue":"2","key":"10_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"J.J. Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004; 55(2):164\u201373.","journal-title":"Ann Neurol"},{"issue":"2","key":"10_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M. Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004; 55(2):174\u20139.","journal-title":"Ann Neurol"},{"issue":"5646","key":"10_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"A.B. Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J et al. Alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 2003; 302(5646):841.","journal-title":"Science"},{"issue":"3","key":"10_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ana.1132","volume":"50","author":"M. Farrer","year":"2001","unstructured":"Farrer M, Chan P, Chen R et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001; 50(3):293\u2013300.","journal-title":"Ann Neurol"},{"issue":"6701","key":"10_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E. Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G et al. The ubiquitin pathway in Parkinson\u2019s disease. Nature 1998; 395(6701):451\u20132.","journal-title":"Nature"},{"issue":"4","key":"10_CR44","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.56.4.555","volume":"56","author":"B.P. Warrenburg van de","year":"2001","unstructured":"van de Warrenburg BP, Lammens M, Lucking CB et al. Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. Neurology 2001; 56(4):555\u20137.","journal-title":"Neurology"},{"issue":"6676","key":"10_CR45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T. Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392(6676):605\u20138.","journal-title":"Nature"},{"issue":"5646","key":"10_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"T.M. Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 2003; 302(5646):819\u201322.","journal-title":"Science"},{"issue":"5674","key":"10_CR47","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"E.M. Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 2004; 304(5674):1158\u201360.","journal-title":"Science"},{"issue":"5604","key":"10_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1077209","volume":"299","author":"V. Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, van Baren MJ et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299(5604):256\u20139.","journal-title":"Science"},{"issue":"12","key":"10_CR49","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R. Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G et al. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 2000; 3(12):1301\u20136.","journal-title":"Nat Neurosci"},{"issue":"5545","key":"10_CR50","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"K.A. Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM et al. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 2001; 294(5545):1346\u20139.","journal-title":"Science"},{"issue":"5674","key":"10_CR51","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/science.1098966","volume":"304","author":"J.T. Greenamyre","year":"2004","unstructured":"Greenamyre JT, Hastings TG. Biomedicine. Parkinson\u2019s\u2014divergent causes, convergent mechanisms. Science 2004; 304(5674):1120\u20132.","journal-title":"Science"},{"issue":"16","key":"10_CR52","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","volume":"22","author":"T.B. Sherer","year":"2002","unstructured":"Sherer TB, Betarbet R, Stout AK et al. An in vitro model of Parkinson\u2019s disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci 2002; 22(16):7006\u201315.","journal-title":"J Neurosci"},{"issue":"6555","key":"10_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y. Trottier","year":"1995","unstructured":"Trottier Y, Lutz Y, Stevanin G et al. Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias. Nature 1995; 378(6555):403\u20136.","journal-title":"Nature"},{"issue":"4","key":"10_CR54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"R.G. Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle J P et al. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 1993; 4(4):393\u20137.","journal-title":"Nat Genet"},{"issue":"9","key":"10_CR55","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/hmg\/2.9.1467","volume":"2","author":"C. Zuhlke","year":"1993","unstructured":"Zuhlke C, Riess O, Schroder K et al. Expansion of the (CAG)n repeat causing Huntington\u2019s disease in 352 patients of German origin. Hum Mol Genet 1993; 2(9):1467\u20139.","journal-title":"Hum Mol Genet"},{"issue":"5334","key":"10_CR56","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M. DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277(5334):1990\u20133.","journal-title":"Science"},{"issue":"4","key":"10_CR57","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","volume":"97","author":"S. Krobitsch","year":"2000","unstructured":"Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 2000; 97(4):1589\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10_CR58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"E.H. Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004; 63(1):66\u201372.","journal-title":"Neurology"},{"issue":"5","key":"10_CR59","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/jnnp.2004.047993","volume":"76","author":"C.M. Kipps","year":"2005","unstructured":"Kipps CM, Duggins AJ, Mahant N et al. Progression of structural neuropathology in preclinical Huntington\u2019s disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005; 76(5):650\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/2510","volume":"20","author":"P.H. Reddy","year":"1998","unstructured":"Reddy PH, Williams M, Charles V et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 1998; 20(2):198\u2013202.","journal-title":"Nat Genet"},{"issue":"6","key":"10_CR61","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0092-8674(00)80464-X","volume":"91","author":"J.M. Ordway","year":"1997","unstructured":"Ordway JM, Tallaksen-Greene S, Gutekunst CA et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997; 91(6):753\u201363.","journal-title":"Cell"},{"issue":"5","key":"10_CR62","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M. DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 1995; 14(5):1075\u201381.","journal-title":"Neuron"},{"issue":"1","key":"10_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng0595-104","volume":"10","author":"Y. Trottier","year":"1995","unstructured":"Trottier Y, Devys D, Imbert G et al. Cellular localization of the Huntington\u2019s disease protein and discrimination of the normal and mutated form. Nat Genet 1995; 10(1):104\u201310.","journal-title":"Nat Genet"},{"issue":"5","key":"10_CR64","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"J.P. Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998; 57(5):369\u201384.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"31","key":"10_CR65","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1073\/pnas.0409283102","volume":"102","author":"H. Mukai","year":"2005","unstructured":"Mukai H, Isagawa T, Goyama E et al. Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc Natl Acad Sci USA 2005; 102(31):10887\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7010","key":"10_CR66","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M. Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004; 431(7010):805\u201310.","journal-title":"Nature"},{"issue":"4","key":"10_CR67","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1471-4159.2004.02376.x","volume":"89","author":"M.D. Kaytor","year":"2004","unstructured":"Kaytor MD, Wilkinson KD, Warren ST. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity. J Neurochem 2004; 89(4):962\u201373.","journal-title":"J Neurochem"},{"issue":"1","key":"10_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"L.B. Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I et al. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol 2003; 465(1):11\u201326.","journal-title":"J Comp Neurol"},{"issue":"16","key":"10_CR69","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"J.M. Raamsdonk Van","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ et al. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 2005; 25(16):4169\u201380.","journal-title":"J Neurosci"},{"issue":"2","key":"10_CR70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","volume":"52","author":"C. Zuccato","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C et al. Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery. Pharmacol Res 2005; 52(2):133\u20139.","journal-title":"Pharmacol Res"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S. Fahn","year":"2003","unstructured":"Fahn S. Description of Parkinson\u2019s disease as a clinical syndrome. Ann N Y Acad Sci 2003; 991:1\u201314.","journal-title":"Ann N Y Acad Sci"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.neuro.28.051804.101459","volume":"28","author":"G.L. Ming","year":"2005","unstructured":"Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005; 28:223\u201350.","journal-title":"Annu Rev Neurosci"},{"issue":"18","key":"10_CR73","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1242\/dev.02541","volume":"133","author":"N.M. Walton","year":"2006","unstructured":"Walton NM, Sutter BM, Chen HX et al. Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain. Development 2006; 133(18):3671\u201381.","journal-title":"Development"},{"issue":"5401","key":"10_CR74","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1126\/science.283.5401.534","volume":"283","author":"C.R. Bjornson","year":"1999","unstructured":"Bjornson CR, Rietze RL, Reynolds BA et al. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283(5401):534\u20137.","journal-title":"Science"},{"issue":"5497","key":"10_CR75","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1126\/science.290.5497.1779","volume":"290","author":"E. Mezey","year":"2000","unstructured":"Mezey E, Chandross KJ, Harta G et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290(5497):1779\u201382.","journal-title":"Science"},{"issue":"12","key":"10_CR76","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","volume":"113","author":"M. Dezawa","year":"2004","unstructured":"Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004; 113(12):1701\u201310.","journal-title":"J Clin Invest"},{"issue":"3","key":"10_CR77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tins.2007.12.001","volume":"31","author":"J.Y. Li","year":"2008","unstructured":"Li JY, Christophersen NS, Hall V et al. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci 2008; 31(3):146\u201353.","journal-title":"Trends Neurosci"},{"issue":"1","key":"10_CR78","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrn2039","volume":"8","author":"M.P. Smidt","year":"2007","unstructured":"Smidt MP, Burbach JP. How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci 2007; 8(1):21\u201332.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10_CR79","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/nm1495","volume":"12","author":"N.S. Roy","year":"2006","unstructured":"Roy NS, Cleren C, Singh SK et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006; 12(11):1259\u201368.","journal-title":"Nat Med"},{"issue":"20","key":"10_CR80","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1523\/JNEUROSCI.21-20-08108.2001","volume":"21","author":"P. Akerud","year":"2001","unstructured":"Akerud P, Canals JM, Snyder EY et al. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson\u2019s disease. J Neurosci 2001; 21(20):8108\u201318.","journal-title":"J Neurosci"},{"issue":"1","key":"10_CR81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrn1829","volume":"7","author":"F.J. Muller","year":"2006","unstructured":"Muller FJ, Snyder EY, Loring JF. Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 2006; 7(1):75\u201384.","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"10_CR82","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"C.R. Freed","year":"2001","unstructured":"Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N Engl J Med 2001; 344(10):710\u20139.","journal-title":"N Engl J Med"},{"issue":"3","key":"10_CR83","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","volume":"54","author":"C.W. Olanow","year":"2003","unstructured":"Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease. Ann Neurol 2003; 54(3):403\u201314.","journal-title":"Ann Neurol"},{"issue":"3","key":"10_CR84","first-page":"589","volume":"96","author":"I. Mendez","year":"2002","unstructured":"Mendez I, Dagher A, Hong M et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 2002; 96(3):589\u201396.","journal-title":"Report of three cases. J Neurosurg"},{"issue":"3","key":"10_CR85","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3171\/jns.2000.92.3.0493","volume":"92","author":"I. Mendez","year":"2000","unstructured":"Mendez I, Hong M, Smith S et al. Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note. J Neurosurg 2000; 92(3):493\u20139.","journal-title":"Technical note. J Neurosurg"},{"issue":"Pt 7","key":"10_CR86","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","volume":"128","author":"I. Mendez","year":"2005","unstructured":"Mendez I, Sanchez-Pernaute R, Cooper O et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease. Brain 2005; 128(Pt 7):1498\u2013510.","journal-title":"Brain"},{"key":"10_CR87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/0470870834.ch3","volume":"231","author":"S.B. Dunnett","year":"2000","unstructured":"Dunnett SB. Functional analysis of fronto-striatal reconstruction by striatal grafts. Novartis Found Symp 2000; 231:21\u201341; discussion-52.","journal-title":"Novartis Found Symp"},{"issue":"4","key":"10_CR88","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s002210050877","volume":"128","author":"P.J. Brasted","year":"1999","unstructured":"Brasted PJ, Watts C, Torres EM et al. Behavioural recovery following striatal transplantation: effects of postoperative training and P-zone volume. Exp Brain Res 1999; 128(4):535\u20138.","journal-title":"Exp Brain Res"},{"issue":"6","key":"10_CR89","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0361-9230(98)00129-4","volume":"47","author":"M.D. Dobrossy","year":"1998","unstructured":"Dobrossy MD, Dunnett SB. Striatal grafts alleviate deficits in response execution in a lateralised reaction time task. Brain Res Bull 1998; 47(6):585\u201393.","journal-title":"Brain Res Bull"},{"issue":"2","key":"10_CR90","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.expneurol.2006.01.013","volume":"199","author":"S.B. Dunnett","year":"2006","unstructured":"Dunnett SB, White A. Striatal grafts alleviate bilateral striatal lesion deficits in operant delayed alternation in the rat. Exp Neurol 2006; 199(2):479\u201389.","journal-title":"Exp Neurol"},{"issue":"15","key":"10_CR91","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1073\/pnas.82.15.5227","volume":"82","author":"A. Fine","year":"1985","unstructured":"Fine A, Dunnett SB, Bjorklund A et al. Cholinergic ventral forebrain grafts into the neocortex improve passive avoidance memory in a rat model of Alzheimer disease. Proc Natl Acad Sci USA 1985; 82(15):5227\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\u20134","key":"10_CR92","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF01406371","volume":"115","author":"T. Itakura","year":"1992","unstructured":"Itakura T, Umemoto M, Kamei I et al. Autotransplantation of peripheral cholinergic neurons into the brains of Alzheimer model rats. Acta Neurochir (Wien) 1992; 115(3\u20134):127\u201332.","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"10_CR93","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nri1843","volume":"6","author":"H.L. Weiner","year":"2006","unstructured":"Weiner HL, Frenkel D. Immunology and immunotherapy of Alzheimer\u2019s disease. Nat Rev Immunol 2006; 6(5):404\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"1\u20132","key":"10_CR94","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0165-5728(99)00003-X","volume":"95","author":"D. Frenkel","year":"1999","unstructured":"Frenkel D, Balass M, Katchalski-Katzir E et al. High affinity binding of monoclonal antibodies to the sequential epitope EFRH of beta-amyloid peptide is essential for modulation of fibrillar aggregation. J Neuroimmunol 1999; 95(1\u20132):136\u201342.","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10_CR95","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-5728(98)00098-8","volume":"88","author":"D. Frenkel","year":"1998","unstructured":"Frenkel D, Balass M, Solomon B. N-terminal EFRH sequence of Alzheimer\u2019s beta-amyloid peptide represents the epitope of its anti-aggregating antibodies. J Neuroimmunol 1998; 88(1\u20132):85\u201390.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"10_CR96","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1073\/pnas.94.8.4109","volume":"94","author":"B. Solomon","year":"1997","unstructured":"Solomon B, Koppel R, Frankel D et al. Disaggregation of Alzheimer beta-amyloid by site-directed mAb. Proc Natl Acad Sci USA 1997; 94(8):4109\u201312.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10_CR97","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1073\/pnas.93.1.452","volume":"93","author":"B. Solomon","year":"1996","unstructured":"Solomon B, Koppel R, Hanan E et al. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide. Proc Natl Acad Sci USA 1996; 93(1):452\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6815","key":"10_CR98","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C. Janus","year":"2000","unstructured":"Janus C, Pearson J, McLaurin J et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer\u2019s disease. Nature 2000; 408(6815):979\u201382.","journal-title":"Nature"},{"issue":"6815","key":"10_CR99","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D. Morgan","year":"2000","unstructured":"Morgan D, Diamond DM, Gottschall PE et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer\u2019s disease. Nature 2000; 408(6815):982\u20135.","journal-title":"Nature"},{"issue":"6740","key":"10_CR100","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D. Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400(6740):173\u20137.","journal-title":"Nature"},{"issue":"1","key":"10_CR101","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","volume":"64","author":"A.J. Bayer","year":"2005","unstructured":"Bayer AJ, Bullock R, Jones RW et al. Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology 2005; 64(1):94\u2013101.","journal-title":"Neurology"},{"issue":"9","key":"10_CR102","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S. Gilman","year":"2005","unstructured":"Gilman S, Koller M, Black RS et al. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005; 64(9):1553\u201362.","journal-title":"Neurology"},{"issue":"4","key":"10_CR103","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","volume":"38","author":"C. Hock","year":"2003","unstructured":"Hock C, Konietzko U, Streffer J R et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease. Neuron 2003; 38(4):547\u201354.","journal-title":"Neuron"},{"issue":"1","key":"10_CR104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","volume":"61","author":"J.M. Orgogozo","year":"2003","unstructured":"Orgogozo JM, Gilman S, Dartigues JF et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003; 61(1):46\u201354.","journal-title":"Neurology"},{"issue":"1","key":"10_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","volume":"14","author":"I. Ferrer","year":"2004","unstructured":"Ferrer I, Boada Rovira M, Sanchez Guerra ML et al. Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer\u2019s disease. Brain Pathol 2004; 14(1):11\u201320.","journal-title":"Brain Pathol"},{"issue":"1","key":"10_CR106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","volume":"64","author":"E. Masliah","year":"2005","unstructured":"Masliah E, Hansen L, Adame A et al. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 2005; 64(1):129\u201331.","journal-title":"Neurology"},{"issue":"10 Suppl 4","key":"10_CR107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.66.10_suppl_4.S89","volume":"66","author":"B. Dass","year":"2006","unstructured":"Dass B, Olanow CW, Kordower JH. Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson\u2019s disease. Neurology 2006; 66(10 Suppl 4):S89\u2013103.","journal-title":"Neurology"},{"issue":"5","key":"10_CR108","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.3171\/foc.2002.13.5.6","volume":"13","author":"M.H. Tuszynski","year":"2002","unstructured":"Tuszynski MH, U HS, Alksne J et al. Growth factor gene therapy for Alzheimer disease. Neurosurg Focus 2002; 13(5):e5.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"10_CR109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1474-4422(02)00006-6","volume":"1","author":"M.H. Tuszynski","year":"2002","unstructured":"Tuszynski MH. Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol 2002; 1(1):51\u20137.","journal-title":"Lancet Neurol"},{"issue":"5","key":"10_CR110","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"M.H. Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11(5):551\u20135.","journal-title":"Nat Med"},{"issue":"41","key":"10_CR111","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.1073\/pnas.0404180101","volume":"101","author":"A. Consiglio","year":"2004","unstructured":"Consiglio A, Gritti A, Dolcetta D et al. Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc Natl Acad Sci USA 2004; 101(41):14835\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10_CR112","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1523\/JNEUROSCI.22-15-06639.2002","volume":"22","author":"D.C. Lie","year":"2002","unstructured":"Lie DC, Dziewczapolski G, Willhoite AR et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 2002; 22(15):6639\u201349.","journal-title":"J Neurosci"},{"issue":"13","key":"10_CR113","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1073\/pnas.1131955100","volume":"100","author":"M. Zhao","year":"2003","unstructured":"Zhao M, Momma S, Delfani K et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci USA 2003; 100(13):7925\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9579","key":"10_CR114","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"M.G. Kaplitt","year":"2007","unstructured":"Kaplitt MG, Feigin A, Tang C et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial. Lancet 2007; 369(9579):2097\u2013105.","journal-title":"Lancet"}],"container-title":["Advances in Experimental Medicine and Biology","Frontiers in Brain Repair"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-5819-8_10.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T20:11:51Z","timestamp":1619813511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-5819-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781441958181","9781441958198"],"references-count":114,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-5819-8_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-5819-8","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}